Search research articles
Contact Us
Filters
Showing results (121-130 of 200) with videos related to
Page
of 20
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
The impact of received dose intensity on the outcome of advanced ovarian cancer
L Repetto, M Pace, S Mammoliti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1993
Advanced ovarian cancer. Carboplatin versus cisplatin
J B Vermorken, W W ten Bokkel Huinink, E A Eisenhauer, et al.
Cancer
|
November 15, 1995
Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients
R Lencioni, C Bartolozzi, D Caramella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1991
Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma
P F Conte, M Bruzzone, F Carnino, et al.
Gynecologic Oncology
|
April 1, 1991
Effect of recombinant human tumor necrosis factor on A2774 human ovarian cancer cell line: potentiation of mitoxantrone cytotoxicity
A Vigani, S Chiara, L Miglietta, et al.
Oncology
|
January 1, 1989
The role of surgery in the combined treatment of locally advanced breast cancer
G Canavese, A Catturich, G Battistini, et al.
British Journal of Cancer
|
February 1, 1989
Phase II study of lonidamine in metastatic breast cancer
P Pronzato, D Amoroso, G Bertelli, et al.
Tumori
|
April 30, 1988
Carboplatin (JM 8), adriamycin and cyclophosphamide (JAC) in advanced ovarian carcinoma: a pilot study
P F Conte, M Bruzzone, S Chiara, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|
February 1, 1987
Metastatic breast cancer: an analysis of prognostic factors in patients treated with aminoglutethimide
L Repetto, P Pronzato, A Ardizzoni, et al.
Seminars in Oncology
|
December 1, 1996
Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer
P F Conte, E Baldini, A Michelotti, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 200) with videos related to
Sort By:
Page
of 20
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
The impact of received dose intensity on the outcome of advanced ovarian cancer
L Repetto, M Pace, S Mammoliti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1993
Advanced ovarian cancer. Carboplatin versus cisplatin
J B Vermorken, W W ten Bokkel Huinink, E A Eisenhauer, et al.
Cancer
|
November 15, 1995
Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients
R Lencioni, C Bartolozzi, D Caramella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1991
Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma
P F Conte, M Bruzzone, F Carnino, et al.
Gynecologic Oncology
|
April 1, 1991
Effect of recombinant human tumor necrosis factor on A2774 human ovarian cancer cell line: potentiation of mitoxantrone cytotoxicity
A Vigani, S Chiara, L Miglietta, et al.
Oncology
|
January 1, 1989
The role of surgery in the combined treatment of locally advanced breast cancer
G Canavese, A Catturich, G Battistini, et al.
British Journal of Cancer
|
February 1, 1989
Phase II study of lonidamine in metastatic breast cancer
P Pronzato, D Amoroso, G Bertelli, et al.
Tumori
|
April 30, 1988
Carboplatin (JM 8), adriamycin and cyclophosphamide (JAC) in advanced ovarian carcinoma: a pilot study
P F Conte, M Bruzzone, S Chiara, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|
February 1, 1987
Metastatic breast cancer: an analysis of prognostic factors in patients treated with aminoglutethimide
L Repetto, P Pronzato, A Ardizzoni, et al.
Seminars in Oncology
|
December 1, 1996
Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer
P F Conte, E Baldini, A Michelotti, et al.
Page
of 20